financetom
Business
financetom
/
Business
/
Ibotta Insider Sold Shares Worth $1,375,176, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Ibotta Insider Sold Shares Worth $1,375,176, According to a Recent SEC Filing
Apr 22, 2024 1:33 PM

04:22 PM EDT, 04/22/2024 (MT Newswires) -- Marisa Daspit, Chief People Officer, on April 22, 2024, sold 15,627 shares in Ibotta ( IBTA ) for $1,375,176. Following the Form 4 filing with the SEC, Daspit has control over a total of 31,154 shares of the company, with 31,154 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1538379/000141588924011299/xslF345X03/form4-04222024_040413.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
-- Imperial Metals Brief: Says Judicial Review Petition Dismissed, Mount Polley to Continue Constructing TSF Raise
-- Imperial Metals Brief: Says Judicial Review Petition Dismissed, Mount Polley to Continue Constructing TSF Raise
Aug 6, 2025
03:56 PM EDT, 08/06/2025 (MT Newswires) -- Price: 3.96, Change: +0.01, Percent Change: +0.25 ...
US appeals court reinstates drug-price conspiracy lawsuit against Sanofi, rival pharma companies
US appeals court reinstates drug-price conspiracy lawsuit against Sanofi, rival pharma companies
Aug 6, 2025
Aug 6 (Reuters) - Drugmakers Sanofi, Eli Lilly ( LLY ), Novo Nordisk and AstraZeneca ( AZN ) must face a lawsuit from two health centers accusing them of conspiring to restrict drug discounts offered to community pharmacies that contract with providers serving low-income patients. A three-judge panel of the 2nd U.S. Circuit Court of Appeals in New York ruled...
Jazz Pharmaceuticals Says US FDA Granted Accelerated Approval for Modeyso
Jazz Pharmaceuticals Says US FDA Granted Accelerated Approval for Modeyso
Aug 6, 2025
03:52 PM EDT, 08/06/2025 (MT Newswires) -- Jazz Pharmaceuticals ( JAZZ ) said Wednesday that the US Food and Drug Administration granted accelerated approval for Modeyso, or dordaviprone, for the treatment of patients 1 year of age and older with recurrent H3 K27M-mutant diffuse midline glioma, a type of brain tumor. The FDA's decision was based on an integrated efficacy...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved